NCT05834634

Brief Summary

In this study, the investigators will assess the Vagus nerve in two groups: Group 1 which include patients with parkinsonism and group 2 which included age and sex matched healthy control. The aim of the study is: detecting the difference between both groups and correlating the changes in the Vagus nerve cross sectional area with the motor and non motor manifestations of parkinsonism

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 28, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

April 18, 2023

Last Update Submit

February 21, 2024

Conditions

Keywords

Vagus nerveParkinsonismNerve ultrasound

Outcome Measures

Primary Outcomes (1)

  • Comparing vagus nerve diameter between healthy controls and patients with parkinsonism

    Detecting the ultrasound changes in Vagus nerve in patients with parkinsonism in comparison to age and sex matched healthy control.

    1 day

Secondary Outcomes (1)

  • Correlation of the Vagus nerve ultrasound changes with the motor and non-motor manifestations of parkinsonism

    1 day

Study Arms (2)

Group 1

Patients with parkinsonism

Device: Ultrasound

Group 2

Healthy age and sex matched controls

Device: Ultrasound

Interventions

The patients and controls will be scanned at the Neurophysiology unit of the Department of Neurology, Neurology, psychiatry and Neurosurgery hospital, Assiut university hospital. The acquisition of ultrasound images was performed using a Philips HD11XE imaging system with an L12-8 linear array probe. Cross-sectional area (CSA) of the right and left Vagus nerves in each subject, perimeter, echogenicity, and fascicular structure will be assessed and measured by tracing the nerve just inside its hyperechoic rim. The nerve will be seen on ultrasound B-mode near the bifurcation of the carotid artery, dorsal to the internal and common carotid arteries, as a structure that is hypoechogenic in the centre and more hyperechogenic on the periphery (24, 25). Both the carotid artery and the internal jugular vein served as anatomical landmarks (25). Two separate CSA measurements, with the probe repositioned for each measurement, will be taken and they will be averaged.

Group 1Group 2

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Patients diagnosed with Parkinsonism including Parkinsons disease diagnosed according to the criteria of the UK British Brain Bank (21) and successive revision (22) attending the neurology outpatient clinic, Department of Neurology and Psychiatry, Assiut University hospital. * Age and sex matched healthy control group, will be recruited from the outpatient

You may qualify if:

  • All patients fulfill the criteria of case definition of parkinsonism.
  • Gender: both sexes are included.
  • Willingness to participate in the study and to be subjected to the disease-related examinations and assessments.
  • Willing and able to provide informed consent.

You may not qualify if:

  • Patients unable to give informed consent.
  • History of chronic psychiatric or other central nervous system pathology and other neurodegenerative disorder(s).
  • Patients with previous surgery in proximity of the Vagus nerve (for example carotid endarterectomy or implantation of Vagus nerve stimulator).
  • Patients with known systemic diseases (such as diabetes mellitus, vascular disease, and peripheral neuropathy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

Parkinsonian Disorders

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement Disorders

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mohamed AR Ahmed

    Assiut University

    PRINCIPAL INVESTIGATOR
  • Nourelhoda AA Haridy

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 18, 2023

First Posted

April 28, 2023

Study Start

December 1, 2023

Primary Completion

December 1, 2024

Study Completion

March 1, 2025

Last Updated

February 22, 2024

Record last verified: 2024-02

Locations